- Home
- GHRS vs ECPG Comparison
GHRS vs ECPG Comparison
Compare GHRS & ECPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | GHRS | ECPG |
|---|---|---|
| Founded | 2018 | 1998 |
| Country | Ireland | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance Companies |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 892.0M | 905.2M |
| IPO Year | 2021 | 1999 |
Fundamental Metrics
Financial Performance| Metric | GHRS | ECPG |
|---|---|---|
| Price | $13.05 | $53.70 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 9 | 3 |
| Target Price | $30.11 | ★ $61.67 |
| AVG Volume (30 Days) | 247.9K | ★ 253.9K |
| Earning Date | 11-06-2025 | 11-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $1,560,869,000.00 |
| Revenue This Year | N/A | $31.88 |
| Revenue Next Year | N/A | $3.57 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 17.52 |
| 52 Week Low | $6.72 | $26.45 |
| 52 Week High | $20.50 | $56.67 |
Technical Indicators
Market Signals| Indicator | GHRS | ECPG |
|---|---|---|
| Relative Strength Index (RSI) | 41.50 | 61.15 |
| Support Level | $13.94 | $52.51 |
| Resistance Level | $15.00 | $56.67 |
| Average True Range (ATR) | 0.84 | 1.79 |
| MACD | -0.15 | 0.08 |
| Stochastic Oscillator | 3.99 | 59.36 |
Price Performance
Historical ComparisonAbout GHRS GH Research PLC
GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment for depression. Its initial focus is on developing novel and proprietary mebufotenin therapies for the treatment of patients with Treatment-Resistant Depression, or TRD. Its portfolio currently includes GH001, a proprietary inhalable mebufotenin product candidate, and GH002, a proprietary intravenous mebufotenin product candidate. The group has only a single segment: Research and Development.
About ECPG Encore Capital Group Inc
Encore Capital Group Inc is an international specialty finance company. It provides debt recovery solutions for consumers and property owners across a broad range of financial assets. The company purchases portfolios of defaulted consumer receivables at deep discounts to face value and manages them by working with individuals as the consumers repay their obligations and work toward financial recovery. Encore has only a reportable segment portfolio purchasing and recovery.